Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN) Misses Q3 EPS by 2c, Revenues Beat

February 27, 2019 5:59 AM

Amarin Corp. (NASDAQ: AMRN) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $77.33 million versus the consensus estimate of $73.87 million.

“The tremendous progress Amarin made in 2018 helps position us for further significant achievement and accelerated revenue growth in the future,” commented John Thero, Amarin’s president and chief executive officer. “Our excitement regarding the REDUCE-IT study results is being reinforced by feedback from healthcare professionals as they begin to understand these unprecedented results and the positive impact it could have on patient care.”

For earnings history and earnings-related data on Amarin Corp. (AMRN) click here.


Corporate News Earnings Management Comments

Next Articles